The use of injectable sonication-induced silk hydrogel for VEGF165 and BMP-2 delivery for elevation of the maxillary sinus floor

Abstract

Sonication-induced silk hydrogels were previously prepared as an injectable bone replacement biomaterial, with a need to improve osteogenic features. Vascular endothelial growth factor (VEGF165) and bone morphogenic protein-2 (BMP-2) are key regulators of angiogenesis and osteogenesis, respectively, during bone regeneration. Therefore, the present study aimed at evaluating in situ forming silk hydrogels as a vehicle to encapsulate dual factors for rabbit maxillary sinus floor augmentation. Sonication-induced silk hydrogels were prepared in vitro and the slow release of VEGF165 and BMP-2 from these silk gels was evaluated by ELISA. For in vivo studies for each time point (4 and 12 weeks), 24 sinus floors elevation surgeries were made bilaterally in 12 rabbits for the following four treatment groups: silk gel (group Silk gel), silk gel/VEGF165 (group VEGF), silk gel/BMP-2 (group BMP-2), silk gel/VEGF165/BMP-2 (group V+B) (n=6 per group). Sequential florescent labeling and radiographic observations were used to record new bone formation and mineralization, along with histological and histomorphometric analysis. At week 4, VEGF165 promoted more tissue infiltration into the gel and accelerated the degradation of the gel material. At this time point, the bone area in group V+B was significantly larger than those in the other three groups. At week 12, elevated sinus floor heights of groups BMP-2 and V+B were larger than those of the Silk gel and VEGF groups, and the V+B group had the largest new bone area among all groups. In addition, a larger blood vessel area formed in the remaining gel areas in groups VEGF and V+B. In conclusion, VEGF165 and BMP-2 released from injectable and biodegradable silk gels promoted angiogenesis and new bone formation, with the two factors demonstrating an additive effect on bone regeneration. These results indicate that silk hydrogels can be used as an injectable vehicle to deliver multiple growth factors in a minimally invasive approach to regenerate irregular bony cavities.

Magnesium ion implantation on a micro/nanostructured titanium surface promotes its bioactivity and osteogenic differentiation function

“…The relative expression level for each gene of interest was normalized to that of the housekeeping gene GAPDH. 38 …”

Surface modification of vascular endothelial growth factor-loaded silk fibroin to improve biological performance of ultra-high-molecular-weight polyethylene via promoting angiogenesis

“…Similarly, Zhang et al 42 found that the single VEGF from the silk gel or silk scaffold only promoted angiogenesis and more tissue infiltration into the gel or scaffold, in which no bone regeneration was observed, while combining VEGF and BMP-2 released from the silk gel or silk scaffold could promote angiogenesis and new bone formation. 48,49 Besides, graft motion in the bone tunnel could be inevitable in ACL reconstruction model, which impeded bone regeneration. It was verified that interfacial implant movement will lead to soft tissue formation instead of bone.…”

A sugar-based phase-transitioning delivery system for bone tissue engineering

“…Others are able to be injected. Hyaluronic acid (Martinez-Sanz et al, 2012), gelatin (Yamamoto et al, 2006) and silk (Zhang et al, 2011) based hydrogels have all shown the capacity to deliver BMP-2 and produce bone in animal models. However, many of these hydrogels comprise of animalderived proteins that can bring associated costs and disease risk.…”